Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 107

1.

Kynurenic acid, an IDO metabolite, controls TSG-6-mediated immunosuppression of human mesenchymal stem cells.

Wang G, Cao K, Liu K, Xue Y, Roberts AI, Li F, Han Y, Rabson AB, Wang Y, Shi Y.

Cell Death Differ. 2018 Jul;25(7):1209-1223. doi: 10.1038/s41418-017-0006-2. Epub 2017 Dec 13.

2.

RNA stability regulates human T cell leukemia virus type 1 gene expression in chronically-infected CD4 T cells.

Lin HC, Simon PJ, Ysla RM, Zeichner SL, Brewer G, Rabson AB.

Virology. 2017 Aug;508:7-17. doi: 10.1016/j.virol.2017.04.029. Epub 2017 May 4.

3.

SHP1 Regulates Bone Mass by Directing Mesenchymal Stem Cell Differentiation.

Jiang M, Zheng C, Shou P, Li N, Cao G, Chen Q, Xu C, Du L, Yang Q, Cao J, Han Y, Li F, Cao W, Liu F, Rabson AB, Roberts AI, Xie W, Wang Y, Shi Y.

Cell Rep. 2016 Nov 15;17(8):2161. doi: 10.1016/j.celrep.2016.10.069. No abstract available.

4.

Downregulation of CXCL12 in mesenchymal stromal cells by TGFβ promotes breast cancer metastasis.

Yu PF, Huang Y, Xu CL, Lin LY, Han YY, Sun WH, Hu GH, Rabson AB, Wang Y, Shi YF.

Oncogene. 2017 Feb 9;36(6):840-849. doi: 10.1038/onc.2016.252. Epub 2016 Sep 26.

5.

Choline-magnesium trisalicylate modulates acute myelogenous leukemia gene expression during induction chemotherapy.

Medina D, David K, Lin Y, Schaar D, Patel V, Gharibo M, Bannerji R, Walton K, Aisner J, Rabson AB, Strair R.

Leuk Lymphoma. 2017 May;58(5):1227-1230. doi: 10.1080/10428194.2016.1225206. Epub 2016 Sep 23. No abstract available.

PMID:
27659510
6.

SHP1 Regulates Bone Mass by Directing Mesenchymal Stem Cell Differentiation.

Jiang M, Zheng C, Shou P, Li N, Cao G, Chen Q, Xu C, Du L, Yang Q, Cao J, Han Y, Li F, Cao W, Liu F, Rabson AB, Roberts AI, Xie W, Wang Y, Shi Y.

Cell Rep. 2016 Jul 19;16(3):769-80. doi: 10.1016/j.celrep.2016.06.035. Epub 2016 Jul 7. Erratum in: Cell Rep. 2016 Nov 15;17 (8):2161.

7.

TNFα-activated mesenchymal stromal cells promote breast cancer metastasis by recruiting CXCR2+ neutrophils.

Yu PF, Huang Y, Han YY, Lin LY, Sun WH, Rabson AB, Wang Y, Shi YF.

Oncogene. 2017 Jan 26;36(4):482-490. doi: 10.1038/onc.2016.217. Epub 2016 Jul 4.

8.

Type I interferons exert anti-tumor effect via reversing immunosuppression mediated by mesenchymal stromal cells.

Shou P, Chen Q, Jiang J, Xu C, Zhang J, Zheng C, Jiang M, Velletri T, Cao W, Huang Y, Yang Q, Han X, Zhang L, Wei L, Rabson AB, Chin YE, Wang Y, Shi Y.

Oncogene. 2016 Nov 17;35(46):5953-5962. doi: 10.1038/onc.2016.128. Epub 2016 Apr 25.

9.

Histone deacetylase inhibitors prevent activation-induced cell death and promote anti-tumor immunity.

Cao K, Wang G, Li W, Zhang L, Wang R, Huang Y, Du L, Jiang J, Wu C, He X, Roberts AI, Li F, Rabson AB, Wang Y, Shi Y.

Oncogene. 2015 Dec 3;34(49):5960-70. doi: 10.1038/onc.2015.46. Epub 2015 Mar 9.

10.

Effects of Wharton's jelly-derived mesenchymal stem cells on neonatal neutrophils.

Khan I, Zhang L, Mohammed M, Archer FE, Abukharmah J, Yuan Z, Rizvi SS, Melek MG, Rabson AB, Shi Y, Weinberger B, Vetrano AM.

J Inflamm Res. 2014 Dec 31;8:1-8. doi: 10.2147/JIR.S71987. eCollection 2015.

11.

Conditional inactivation of PDCD2 induces p53 activation and cell cycle arrest.

Granier CJ, Wang W, Tsang T, Steward R, Sabaawy HE, Bhaumik M, Rabson AB.

Biol Open. 2014 Aug 22;3(9):821-31. doi: 10.1242/bio.20148326.

12.

A triple combination of atorvastatin, celecoxib and tipifarnib strongly inhibits pancreatic cancer cells and xenograft pancreatic tumors.

Ding N, Cui XX, Gao Z, Huang H, Wei X, Du Z, Lin Y, Shih WJ, Rabson AB, Conney AH, Hu C, Zheng X.

Int J Oncol. 2014 Jun;44(6):2139-45. doi: 10.3892/ijo.2014.2350. Epub 2014 Mar 19.

13.

Mesenchymal stem cells use IDO to regulate immunity in tumor microenvironment.

Ling W, Zhang J, Yuan Z, Ren G, Zhang L, Chen X, Rabson AB, Roberts AI, Wang Y, Shi Y.

Cancer Res. 2014 Mar 1;74(5):1576-87. doi: 10.1158/0008-5472.CAN-13-1656. Epub 2014 Jan 22.

14.

Inhibition of type I interferon signalling prevents TLR ligand-mediated proteinuria.

Gurkan S, Cabinian A, Lopez V, Bhaumik M, Chang JM, Rabson AB, Mundel P.

J Pathol. 2013 Oct;231(2):248-56.

PMID:
24151637
15.

An osteopontin-integrin interaction plays a critical role in directing adipogenesis and osteogenesis by mesenchymal stem cells.

Chen Q, Shou P, Zhang L, Xu C, Zheng C, Han Y, Li W, Huang Y, Zhang X, Shao C, Roberts AI, Rabson AB, Ren G, Zhang Y, Wang Y, Denhardt DT, Shi Y.

Stem Cells. 2014 Feb;32(2):327-37. doi: 10.1002/stem.1567.

16.

Bringing back the help: autologous bone marrow infusion restores CD4+ T cells in AIDS patients with chronic liver disease.

Rabson AB.

Cell Death Dis. 2013 Oct 10;4:e849. doi: 10.1038/cddis.2013.373. No abstract available.

17.

'Reduced malignancy as a mechanism for longevity in mice with adenylyl cyclase type 5 disruption'.

De Lorenzo MS, Chen W, Baljinnyam E, Carlini MJ, La Perle K, Bishop SP, Wagner TE, Rabson AB, Vatner DE, Puricelli LI, Vatner SF.

Aging Cell. 2014 Feb;13(1):102-10. doi: 10.1111/acel.12152. Epub 2013 Oct 13.

18.

PDCD2 functions in cancer cell proliferation and predicts relapsed leukemia.

Barboza N, Minakhina S, Medina DJ, Balsara B, Greenwood S, Huzzy L, Rabson AB, Steward R, Schaar DG.

Cancer Biol Ther. 2013 Jun;14(6):546-55. doi: 10.4161/cbt.24484.

19.

CCR2-dependent recruitment of macrophages by tumor-educated mesenchymal stromal cells promotes tumor development and is mimicked by TNFα.

Ren G, Zhao X, Wang Y, Zhang X, Chen X, Xu C, Yuan ZR, Roberts AI, Zhang L, Zheng B, Wen T, Han Y, Rabson AB, Tischfield JA, Shao C, Shi Y.

Cell Stem Cell. 2012 Dec 7;11(6):812-24. doi: 10.1016/j.stem.2012.08.013. Epub 2012 Nov 15.

20.

Effects of 12-O-tetradecanoylphorbol-13-acetate in combination with gemcitabine on Panc-1 pancreatic cancer cells cultured in vitro or Panc-1 tumors grown in immunodeficient mice.

Zheng X, Cui XX, Gao Z, Verano M, Huang MT, Liu Y, Rabson AB, Conney AH.

Int J Oncol. 2012 Dec;41(6):2269-75. doi: 10.3892/ijo.2012.1651. Epub 2012 Oct 4.

PMID:
23041978
21.

PDCD2 knockdown inhibits erythroid but not megakaryocytic lineage differentiation of human hematopoietic stem/progenitor cells.

Kokorina NA, Granier CJ, Zakharkin SO, Davis S, Rabson AB, Sabaawy HE.

Exp Hematol. 2012 Dec;40(12):1028-1042.e3. doi: 10.1016/j.exphem.2012.08.004. Epub 2012 Aug 22.

22.

PDCD2 controls hematopoietic stem cell differentiation during development.

Kramer J, Granier CJ, Davis S, Piso K, Hand J, Rabson AB, Sabaawy HE.

Stem Cells Dev. 2013 Jan 1;22(1):58-72. doi: 10.1089/scd.2012.0074. Epub 2012 Aug 16.

23.
24.

How mesenchymal stem cells interact with tissue immune responses.

Shi Y, Su J, Roberts AI, Shou P, Rabson AB, Ren G.

Trends Immunol. 2012 Mar;33(3):136-43. doi: 10.1016/j.it.2011.11.004. Epub 2012 Jan 7. Review.

25.

Caloric restriction reduces growth of mammary tumors and metastases.

De Lorenzo MS, Baljinnyam E, Vatner DE, Abarzúa P, Vatner SF, Rabson AB.

Carcinogenesis. 2011 Sep;32(9):1381-7. doi: 10.1093/carcin/bgr107. Epub 2011 Jun 10.

26.

Synthesis and Processing of Viral RNA.

Rabson AB, Graves BJ.

In: Coffin JM, Hughes SH, Varmus HE, editors. Retroviruses. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 1997.

27.

The tumor suppressor gene WWOX links the canonical and noncanonical NF-κB pathways in HTLV-I Tax-mediated tumorigenesis.

Fu J, Qu Z, Yan P, Ishikawa C, Aqeilan RI, Rabson AB, Xiao G.

Blood. 2011 Feb 3;117(5):1652-61. doi: 10.1182/blood-2010-08-303073. Epub 2010 Nov 29.

28.

Trisomy 21 leukemias: finding the hits that matter.

Rabson AB.

Oncogene. 2010 Nov 18;29(46):6099-101. doi: 10.1038/onc.2010.353. Epub 2010 Aug 16.

PMID:
20711238
29.

Immune activation induces immortalization of HTLV-1 LTR-Tax transgenic CD4+ T cells.

Swaims AY, Khani F, Zhang Y, Roberts AI, Devadas S, Shi Y, Rabson AB.

Blood. 2010 Oct 21;116(16):2994-3003. doi: 10.1182/blood-2009-07-231050. Epub 2010 Jul 15.

30.

Regulation of the expression and activity of the antiangiogenic homeobox gene GAX/MEOX2 by ZEB2 and microRNA-221.

Chen Y, Banda M, Speyer CL, Smith JS, Rabson AB, Gorski DH.

Mol Cell Biol. 2010 Aug;30(15):3902-13. doi: 10.1128/MCB.01237-09. Epub 2010 Jun 1.

31.

MEOX2 regulates nuclear factor-kappaB activity in vascular endothelial cells through interactions with p65 and IkappaBbeta.

Chen Y, Rabson AB, Gorski DH.

Cardiovasc Res. 2010 Sep 1;87(4):723-31. doi: 10.1093/cvr/cvq117. Epub 2010 Apr 26.

32.

Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression.

Ren G, Su J, Zhang L, Zhao X, Ling W, L'huillie A, Zhang J, Lu Y, Roberts AI, Ji W, Zhang H, Rabson AB, Shi Y.

Stem Cells. 2009 Aug;27(8):1954-62. doi: 10.1002/stem.118.

34.

The Raz mTaz of human mesenchymal stem cells.

Banerjee D, Glod J, Rabson AB.

Stem Cells Dev. 2007 Oct;16(5):691-3. No abstract available.

PMID:
17999591
35.

Curcumin downregulates the constitutive activity of NF-kappaB and induces apoptosis in novel mouse melanoma cells.

Marín YE, Wall BA, Wang S, Namkoong J, Martino JJ, Suh J, Lee HJ, Rabson AB, Yang CS, Chen S, Ryu JH.

Melanoma Res. 2007 Oct;17(5):274-83.

PMID:
17885582
36.

Atorvastatin and celecoxib inhibit prostate PC-3 tumors in immunodeficient mice.

Zheng X, Cui XX, Avila GE, Huang MT, Liu Y, Patel J, Kong AN, Paulino R, Shih WJ, Lin Y, Rabson AB, Reddy BS, Conney AH.

Clin Cancer Res. 2007 Sep 15;13(18 Pt 1):5480-7.

37.

Alternative pathways of NF-kappaB activation: a double-edged sword in health and disease.

Xiao G, Rabson AB, Young W, Qing G, Qu Z.

Cytokine Growth Factor Rev. 2006 Aug;17(4):281-93. Epub 2006 Jun 21. Review.

PMID:
16793322
38.

Effects of 12-O-tetradecanoylphorbol-13-acetate (TPA) in combination with paclitaxel (Taxol) on prostate Cancer LNCaP cells cultured in vitro or grown as xenograft tumors in immunodeficient mice.

Zheng X, Chang RL, Cui XX, Avila GE, Hebbar V, Garzotto M, Shih WJ, Lin Y, Lu SE, Rabson AB, Kong AN, Conney AH.

Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3444-51.

39.

Novel multi-component nanopharmaceuticals derived from poly(ethylene) glycol, retro-inverso-Tat nonapeptide and saquinavir demonstrate combined anti-HIV effects.

Wan L, Zhang X, Gunaseelan S, Pooyan S, Debrah O, Leibowitz MJ, Rabson AB, Stein S, Sinko PJ.

AIDS Res Ther. 2006 Apr 24;3:12.

40.

Role of NF-kappaB in regulation of PXR-mediated gene expression: a mechanism for the suppression of cytochrome P-450 3A4 by proinflammatory agents.

Gu X, Ke S, Liu D, Sheng T, Thomas PE, Rabson AB, Gallo MA, Xie W, Tian Y.

J Biol Chem. 2006 Jun 30;281(26):17882-9. Epub 2006 Apr 10.

41.

Adenovirus infection and cytotoxicity of primary mantle cell lymphoma cells.

Medina DJ, Sheay W, Osman M, Goodell L, Martin J, Rabson AB, Strair RK.

Exp Hematol. 2005 Nov;33(11):1337-47.

PMID:
16263418
42.

Enhancement of TPA-induced growth inhibition and apoptosis in myeloid leukemia cells by BAY 11-7082, an NF-kappaB inhibitor.

Hansson A, Marín YE, Suh J, Rabson AB, Chen S, Huberman E, Chang RL, Conney AH, Zheng X.

Int J Oncol. 2005 Oct;27(4):941-8.

PMID:
16142309
43.

Regulation of Bcl-3 through interaction with the Lck tyrosine kinase.

Zhao Y, Ramakrishnan A, Kim KE, Rabson AB.

Biochem Biophys Res Commun. 2005 Sep 30;335(3):865-73.

PMID:
16099425
44.

Inhibitory effects of 12-O-tetradecanoylphorbol-13-acetate alone or in combination with all-trans retinoic acid on the growth of cultured human pancreas cancer cells and pancreas tumor xenografts in immunodeficient mice.

Avila GE, Zheng X, Cui XX, Ryan AD, Hansson A, Suh J, Rabson AB, Chang RL, Shih WJ, Lin Y, Crowell P, Lu YP, Lou YR, Conney AH.

J Pharmacol Exp Ther. 2005 Oct;315(1):170-87. Epub 2005 Jun 23.

PMID:
15976015
45.
46.

From microarray to bedside: targeting NF-kappaB for therapy of lymphomas.

Rabson AB, Weissmann D.

Clin Cancer Res. 2005 Jan 1;11(1):2-6. Review. No abstract available.

47.

Synthesis of poly(ethylene glycol)-based saquinavir prodrug conjugates and assessment of release and anti-HIV-1 bioactivity using a novel protease inhibition assay.

Gunaseelan S, Debrah O, Wan L, Leibowitz MJ, Rabson AB, Stein S, Sinko PJ.

Bioconjug Chem. 2004 Nov-Dec;15(6):1322-33.

PMID:
15546199
48.

Hypoxia and defective apoptosis drive genomic instability and tumorigenesis.

Nelson DA, Tan TT, Rabson AB, Anderson D, Degenhardt K, White E.

Genes Dev. 2004 Sep 1;18(17):2095-107. Epub 2004 Aug 16.

49.

Drug targeting of HIV-1 RNA.DNA hybrid structures: thermodynamics of recognition and impact on reverse transcriptase-mediated ribonuclease H activity and viral replication.

Li TK, Barbieri CM, Lin HC, Rabson AB, Yang G, Fan Y, Gaffney BL, Jones RA, Pilch DS.

Biochemistry. 2004 Aug 3;43(30):9732-42.

PMID:
15274628
50.

NF-kappaB activation in human prostate cancer: important mediator or epiphenomenon?

Suh J, Rabson AB.

J Cell Biochem. 2004 Jan 1;91(1):100-17. Review.

PMID:
14689584

Supplemental Content

Loading ...
Support Center